Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Survival after radical prostatectomy vs. radiation therapy in ductal carcinoma of the prostate.
Chierigo F, Borghesi M, Würnschimmel C, Flammia RS, Horlemann B, Sorce G, Höh B, Tian Z, Saad F, Graefen M, Gallucci M, Briganti A, Montorsi F, Chun FKH, Shariat SF, Mantica G, Suardi N, Terrone C, Karakiewicz PI. Chierigo F, et al. Among authors: horlemann b. Int Urol Nephrol. 2022 Jan;54(1):89-95. doi: 10.1007/s11255-021-03070-8. Epub 2021 Nov 19. Int Urol Nephrol. 2022. PMID: 34797483
Improvement in overall and cancer-specific survival in contemporary, metastatic prostate cancer chemotherapy exposed patients.
Hoeh B, Würnschimmel C, Flammia RS, Horlemann B, Sorce G, Chierigo F, Tian Z, Saad F, Graefen M, Gallucci M, Briganti A, Terrone C, Shariat SF, Tilki D, Kluth LA, Mandel P, Chun FKH, Karakiewicz PI. Hoeh B, et al. Among authors: horlemann b. Prostate. 2021 Dec;81(16):1374-1381. doi: 10.1002/pros.24235. Epub 2021 Sep 15. Prostate. 2021. PMID: 34523162
Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patients.
Hoeh B, Würnschimmel C, Flammia RS, Horlemann B, Sorce G, Chierigo F, Tian Z, Saad F, Graefen M, Gallucci M, Briganti A, Terrone C, Shariat SF, Kluth LA, Mandel P, Chun FKH, Karakiewicz PI. Hoeh B, et al. Among authors: horlemann b. Prostate. 2022 Jan;82(1):120-131. doi: 10.1002/pros.24253. Epub 2021 Oct 18. Prostate. 2022. PMID: 34662443
Survival benefit of chemotherapy in a contemporary cohort of metastatic urachal carcinoma.
Flammia RS, Chierigo F, Würnschimmel C, Horlemann B, Hoeh B, Sorce G, Tian Z, Leonardo C, Tilki D, Terrone C, Saad F, Shariat SF, Montorsi F, Chun FK, Gallucci M, Karakiewicz PI. Flammia RS, et al. Among authors: horlemann b. Urol Oncol. 2022 Apr;40(4):165.e9-165.e15. doi: 10.1016/j.urolonc.2021.09.008. Epub 2021 Oct 20. Urol Oncol. 2022. PMID: 34686429
Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patients.
Hoeh B, Hohenhorst JL, Flammia R, Horlemann B, Sorce G, Chierigo F, Tian Z, Saad F, Graefen M, Gallucci M, Briganti A, Terrone C, Shariat SF, Kluth LA, Becker A, Chun FKH, Karakiewicz PI. Hoeh B, et al. Among authors: horlemann b. Int Urol Nephrol. 2022 Jan;54(1):81-87. doi: 10.1007/s11255-021-03055-7. Epub 2021 Nov 16. Int Urol Nephrol. 2022. PMID: 34783982 Free PMC article.
Effect of Chemotherapy on Overall Survival in Contemporary Metastatic Prostate Cancer Patients.
Hoeh B, Würnschimmel C, Flammia RS, Horlemann B, Sorce G, Chierigo F, Tian Z, Saad F, Graefen M, Gallucci M, Briganti A, Terrone C, Shariat SF, Tilki D, Kluth LA, Mandel P, Chun FKH, Karakiewicz PI. Hoeh B, et al. Among authors: horlemann b. Front Oncol. 2021 Nov 23;11:778858. doi: 10.3389/fonc.2021.778858. eCollection 2021. Front Oncol. 2021. PMID: 34888250 Free PMC article.
Plasmacytoid variant urothelial carcinoma of the bladder: effect of radical cystectomy and chemotherapy in non-metastatic and metastatic patients.
Sorce G, Flammia RS, Hoeh B, Chierigo F, Horlemann B, Würnschimmel C, Tian Z, Graefen M, Terrone C, Gallucci M, Chun FKH, Saad F, Shariat SF, Montorsi F, Briganti A, Karakiewicz PI. Sorce G, et al. Among authors: horlemann b. World J Urol. 2022 Jun;40(6):1481-1488. doi: 10.1007/s00345-022-03940-5. Epub 2022 Jan 27. World J Urol. 2022. PMID: 35084543
Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups.
Hoeh B, Würnschimmel C, Flammia RS, Horlemann B, Sorce G, Chierigo F, Tian Z, Saad F, Graefen M, Gallucci M, Briganti A, Terrone C, Shariat SF, Tilki D, Kluth LA, Mandel P, Chun FKH, Karakiewicz PI. Hoeh B, et al. Among authors: horlemann b. Prostate. 2022 May;82(6):676-686. doi: 10.1002/pros.24312. Epub 2022 Feb 21. Prostate. 2022. PMID: 35188981
15 results